Momentum Therapeutics

Momentum Therapeutics is a pioneering biotech company headquartered in Boston, Massachusetts, focused on harnessing the biology of aging to develop therapies that restore cellular resilience and prevent neurodegeneration. The company targets age-associated conditions of the central and peripheral nervous systems, combining in silico, in vitro, and in vivo approaches to discover how existing and novel drugs can restore protein landscape configurations disrupted in aging and degenerative diseases. Using a proteomics dataset of over 7,000 protein levels and access to a 1,300-protein library, Momentum identifies protein modules that change in the aged brain to find known and novel drug targets. The company is backed by Zentynel Frontier Investments and AIR Capital VC, and is affiliated with the Harvard Innovation Labs and the Termeer Institute.